Literature DB >> 6225586

Maternal cell-mediated immunity in pregnancy--lymphocyte responses of mothers and their non-pregnant HLA identical sisters to paternal HLA.

M P Moore, I L Sargent, A Ting, C W Redman.   

Abstract

The mixed lymphocyte reactions (MLR) of normal pregnant women and their non-pregnant HLA identical sisters have been compared, using paternal and unrelated lymphocytes as stimulator cells. Primary and secondary responses were differentiated by studying 7 day MLR time courses. All responses were of a primary nature, with neither stimulation nor suppression of the maternal MLR. These data clearly demonstrate the absence of maternal cellular sensitization to fetal (paternal) HLA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6225586      PMCID: PMC1536190     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  6 in total

1.  Cytotoxic leucocyte iso-antibodies formed during the first pregnancy.

Authors:  J Overweg; C P Engelfriet
Journal:  Vox Sang       Date:  1969-02       Impact factor: 2.144

2.  In vitro foeto-maternal lymphocyte responses at delivery: no gross changes in MLC and PLT responsiveness.

Authors:  T Moen; M Moen; V Palbo; E Thorsby
Journal:  J Reprod Immunol       Date:  1980-11       Impact factor: 4.054

3.  Maternal-fetal relation. II. Further characterization of an immunologic blocking factor that develops during pregnancy.

Authors:  R E Rocklin; J L Kitzmiller; M R Garvoy
Journal:  Clin Immunol Immunopathol       Date:  1982-03

4.  Suppression of mixed lymphocyte reactions by pregnancy serum.

Authors:  J G Bissenden; N R Ling; P Mackintosh
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

5.  The human mixed-lymphocyte culture (MLC) interaction after in vivo allo-immunization. II. HL-A specificity of early proliferative response.

Authors:  H Bondevik; E Thorsby
Journal:  Cell Immunol       Date:  1974-09       Impact factor: 4.868

6.  Maternal cell-mediated immunity in normal and pre-eclamptic pregnancy.

Authors:  I L Sargent; C W Redman; G M Stirrat
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.